LataMed AI Corp.
LataMed AI Corp.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | ||||||||||||||
Assets Current | ||||||||||||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Intangible Assets Current | 8 | 8 | - | - | - | - | - | - | - | |||||
Assets | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities And Stockhold… | ||||||||||||||
Stockholders Equity | ||||||||||||||
Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | 7 | 7 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |||||
Liabilities Current | ||||||||||||||
Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Convertible Notes Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Preferred Stock Value | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 37 | 37 | 29 | 29 | 29 | 29 | 29 | 28 | 28 | |||||
Retained Earnings Accumulated Deficit | -30 | -30 | -30 | -29 | -29 | -29 | -29 | -28 | -28 | |||||
Liabilities And Stockholders Equity | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 275 | 280 | 280 | 280 | 280 | 280 | 280 | 280 | 280 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 7,932,000 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | |||||
Common Stock Shares Authorized | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 300 | 700 | |||||
Common Stock Shares Issued | 36 | 0 | 44 | 0 | 0 | 29 | 29 | 0 | 110 | |||||
Shares Outstanding | 36 | 0 | 44 | 0 | 0 | 29 | 29 | 0 | 110 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -11.59% | 47.83% | - | - | - | - | - | - | - | - | - | - |
| 2025 | -49.00% | -59.00% | -59.00% | -10.84% | 58.56% | 58.56% | 0.00% | 0.00% | 0.00% | 56.76% | 73.65% | - |
| 2024 | - | - | - | 0.00% | 16.67% | -99.75% | -13.31% | -46.28% | -46.28% | 0.00% | -49.00% | -59.00% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
LataMed AI Corp. (LMED) — SEC Financial Statements & Analysis
LataMed AI Corp. (LMED) is a services-computer programming, data processing, etc. company, incorporated in NV. LataMed AI Corp. trades on None, OTC as: LMED, LMEDD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), LataMed AI Corp. reported a Debt-to-Equity ratio of 0.11x. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.11x
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is LataMed AI Corp. in?
LataMed AI Corp. (LMED) operates in the Services-Computer Programming, Data Processing, Etc. industry.
What exchange does LMED trade on?
LataMed AI Corp. (LMED) trades on the None, OTC.
Where is LataMed AI Corp. incorporated?
LataMed AI Corp. is incorporated in NV.